Cognitive Behaviour Therapy for Patients With IBS (EFI)
Primary Purpose
Irritable Bowel Syndrome, Constipation, Abdominal Pain
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Diet modifications
Cognitive behavioral therapy
Sponsored by
About this trial
This is an interventional treatment trial for Irritable Bowel Syndrome focused on measuring Obstructed constipation, Quality of life
Eligibility Criteria
Inclusion Criteria:
- Age 18-75
- IBS
Exclusion Criteria:
- Malignancy
- Known psychiatric disorders
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
Diet modifications
Cognitive therapy
Arm Description
Diet consultation and life style modifications for 6 sessions
6 sessions of cognitive behavioral therapy
Outcomes
Primary Outcome Measures
Symptom score
Secondary Outcome Measures
Quality of life assessment
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT00788658
Brief Title
Cognitive Behaviour Therapy for Patients With IBS
Acronym
EFI
Official Title
Cognitive Behavior Therapy (CBT) as Compared With Standard Therapy for Patients With IBS and Other Functional Gastrointestinal Disorders
Study Type
Interventional
2. Study Status
Record Verification Date
April 2016
Overall Recruitment Status
Completed
Study Start Date
December 2008 (undefined)
Primary Completion Date
December 2010 (Actual)
Study Completion Date
December 2010 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rabin Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Irritable bowel syndrome (IBS) affects approximately 10-15% of the adult population. This condition is characterized by abdominal pain, altered bowel habit, abdominal bloating and reduced quality of life. Options for treating IBS include pharmacotherapy, psychotherapy, hypnotherapy and cognitive behavior therapy (CBT). Available data on the effectiveness of CBT in IBS patients in Israel are scarce.
The aim of the present study is to assess effectiveness of CBT as compared with standard therapy for IBS patients in Israel The course of CBT consisted of up to six 40 min sessions, and included education about IBS and techniques to reduce focusing on symptoms and to manage stress.Standard therapy includs life style modifications.
The primary outcome measure was the score on a symptom-severity scale specific to IBS.
Detailed Description
Symptomatic treatment of patients would not be modified
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Irritable Bowel Syndrome, Constipation, Abdominal Pain, Depression
Keywords
Obstructed constipation, Quality of life
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Diet modifications
Arm Type
Placebo Comparator
Arm Description
Diet consultation and life style modifications for 6 sessions
Arm Title
Cognitive therapy
Arm Type
Active Comparator
Arm Description
6 sessions of cognitive behavioral therapy
Intervention Type
Behavioral
Intervention Name(s)
Diet modifications
Other Intervention Name(s)
Diet
Intervention Description
Diet consultation
Intervention Type
Behavioral
Intervention Name(s)
Cognitive behavioral therapy
Other Intervention Name(s)
CBT
Intervention Description
Cognitive behavioral therapy
Primary Outcome Measure Information:
Title
Symptom score
Time Frame
3 months
Secondary Outcome Measure Information:
Title
Quality of life assessment
Time Frame
3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18-75
IBS
Exclusion Criteria:
Malignancy
Known psychiatric disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ram Dickman, MD
Organizational Affiliation
RMC
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Cognitive Behaviour Therapy for Patients With IBS
We'll reach out to this number within 24 hrs